Posts

Special Issue of Pharmacopsychiatry on Psychedelics in Psychiatry 2021 – the characteristics of disruptive treatments

The July 2021 special issue of Psychopharmacology is dedicated to the renaissance of psychedelics in psychiatry that has occurred during the past couple of years. “Psychedelics in Psychiatry 2021” contains four interesting review articles on different aspects of its historic development and current research as treatment in mood disorders and its effects in psychotherapy.
Together with Gerhard Gründer Henrik Jungaberle has co-authored a paper on “The potential role of psychedelic drugs in mental health care of the future”.

TV: Andrea Jungaberle urges caution in “Radical Ideals: Drugs? Legalize!” on SWR3/ARD Mediathek

This is how Gülseren Ölcüm phrases the content of her episode in the ARD Mediathek: “Drugs as a cure for the soul? Gülseren Ölcüm meets activists who use psychedelics to expand their consciousness. And doctors who want to use them to treat the mentally ill. They are fighting for easier access. Some of them go further than the law allows.”

Conference: INSIGHT 2021 – an invitation to Berlin. Psychedelic research, therapy and drug development in Berlin

At INSIGHT 2021, scientists and therapists, pharmaceutical industry and anthropology, philosophers, and chemists will come together to determine the potential place of LSD, psilocybin, DMT, MDMA, and other psychedelic substances in the treatment of mental disorders. In addition, we will discuss the use of non-pharmacological methods to alter and cultivate states of consciousness and all that it takes to build such unusual states of consciousness a legitimate and safe place in society.

Writing the histories of psychedelic research: Wirtschaftswoche on German LSD-Researcher Hanscarl Leuner

German journalist Marlene Halser on the LSD-researcher Hanscarl Leuner
“Psychedelic mushrooms are in demand on the stock market – this man paved the way for them” (Wirtschaftswoche)

For almost 30 years, Hanscarl Leuner treated people with LSD and psilocybin at the University Hospital in Göttingen. Substances in which highly valued start-ups are currently investing – while the German researcher has been relegated to the sidelines of society.”
… and a free link to “The History of Psychedelics in Psychiatry”

Video: Psychedelic therapy serious – The physician portal esanum reports about the OVID Clinic Berlin

Pharmacologically based long-term therapies are often the treatment of choice for depression. Augmented psychotherapy, which uses mind-altering substances such as ketamine, is a new approach to helping depressed people. The altered states of consciousness induced in this way are then therapeutically integrated This treatment method, which is still relatively new in Germany, is the focus of Dr. med. Andrea Jungaberle and her colleagues in their clinic in Berlin Friedrichshain. Esanum visited the interdisciplinary team and informed us about the innovative procedure.
The esanum physician network has made a video report about the newly opened OVID Clinic Berlin. In it, Andrea Jungaberle, MD, Sergio Pérez and members of the team of therapists present the concept for psychedelic-augmented psychotherapy. Augmented means “amplified, expanded, intensified”.

Radio: “”High sein” – Henrik Jungaberle on a new edition of the drug education book in Deutschlandfunk Corso

“For anyone who wants to get a differentiated picture”.
Alcohol, coke, pills – the list of available drugs is long, and so is the list of addictions. “Being High” is a handbook that casts a nuanced picture on drugs of all kinds. “We have a very dysfunctional relationship with the people who use them,” author Henrik Jungaberle told Dlf.

Henrik Jungaberle in a Corso conversation with Ulrich Biermann

Podcast: Drugs are the answer to what question after all? Henrik Jungaberle in Wieprechts Truths

Drugs are the answer to what questions yet the same?

In a conversation with scientist and drug expert Henrik Jungaberle, Volker Wieprecht rethinks his plan to celebrate his 75th birthday with an opium intoxication. Why actually drugs and if so, for what purpose?

Wieprecht’s Wahrheiten is a podcast for everyone who wants to explore (with him) the deeper meaning of life.

Podcast: Henrik in conversation with Darek Dwanda on values and programs of the MIND Foundation

Berlin’s MIND Foundation is one of Europe’s largest psychedelic therapy organizations with global aspirations. MIND has a range of amazing programs for therapists, academics, and anyone else interested in new psychedelic therapies. In this episode we discuss a range of issues including European psychedelic landscape, ethics of Psychedelic-Assisted Therapies, cultural issues, issues of growth, and many other issues related to healing with psychedelics.

Conference: #drugscience2017 – Research, practice, and global change in 21st century drug science

The #drucscience2017-conference presented speakers from medicine, psychotherapy, neurosciences, pharmacology, public health and anthropology to discuss the state of the art in drug science.

Essay: Ecstasy – Expedition to an Unknown Land in Spektrum der Wissenschaft Spezial: Rituale. Was unser Leben zusammenhält

Ecstasy derives from the Greek and means something like “being outside oneself” and “stepping out,” which means a temporary shifting of the personal coordinate system. This holds the chance of a new perspective, but also the danger of losing oneself. The general characteristics of altered states of waking consciousness include changes in self-, world-, and time-perception, especially emotionalization, intensification of visual and auditory experience, bodily perceptions, and intensified experience of meaning. As a rule, in such states the experience shifts away from the ego-like controlled, to the intoxicating being carried in a stream of fragmentary inner events. It is precisely this passive “being carried” that can have a seductive and “habituating” quality for unstable people.